VACCINE USAGE: VARIVAX is a vaccine indicated for active immunization for the prevention of varicella in individuals 12 months of age and older.
VACCINE DOSAGE: each dose is approximately 0.5 mL after reconstitution and is administered by subcutaneous injection.
CHILDREN (12 MONTHS TO 12 YEARS OF AGE):
- If a second dose is administered, there should be a minimum interval of 3 months between doses.
ADOLESCENTS (≥13 YEARS OF AGE) AND ADULTS:
- Two doses, to be administered a minimum of 4 weeks apart.
VACCINE INGEDIENTS: sucrose, phosphate, glutamate, gelatin. Monosodium L-glutamate, sodium phosphate dibasic, potassium phosphate monobasic, EDTA, residual components of MRC-5 cells including DNA and protein, neomycin, fetal bovine serum, human diploid cell cultures.
LIVE VIRUS VACCINE THAT HAS THE POTENTIAL TO SHED
ADVERSE VACCINE REACTIONS: fever, varicella-like rash, anaphylaxis (including anaphylactic shock), pneumonia, facial edema, necrotizing, retinitis, aplastic anemia, thrombocytopenia, varicella (vaccine strain), encephalitis, Guillain-Barre syndrome, Bell’s palsy, non- febrile seizures, aseptic meningitis, dizziness, paresthesia.